Skip to content

Goodwill at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$21.74B0.0%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.09B0.0%
Gilead Sciences logo
Gilead SciencesGILD
$8.31B0.0%
Precigen logo
PrecigenPGEN
$15.23M-20.4%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$65.95M0.0%
BioLife Solutions logo
BioLife SolutionsBLFS
$208.59M-1.8%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$907.23M+54.1%
Enterprise value$898.76M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's goodwill?
Sana Biotechnology (SANA) reported goodwill of $140.63M in Q1 2026.
How has Sana Biotechnology's goodwill changed year-over-year?
Sana Biotechnology's goodwill decreased by 0.0% year-over-year, from $140.63M to $140.63M.
What is the long-term trend for Sana Biotechnology's goodwill?
Over 5 years (2020 to 2025), Sana Biotechnology's goodwill has grown at a 0.0% compound annual growth rate (CAGR), from $140.63M to $140.63M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.